NUVECTIS PHARMA, INC.
(NASDAQ: NVCT)
Press Releases
26
Mar
2025
Fort Lee, NJ, March 26, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming presentations for NXP900 at the upcoming 2025 American Association for Cancer Research Meeting (2025 AACR), taking place from April 25th to April 30th in Chicago, IL. Presentati...
14
Mar
2025
FORT LEE, NJ, March 14, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. ("Nuvectis", "Company"), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will participate in a fireside chat at the 37th Annual Roth Conference taking place March 17th-19th in Dana Point, California. Event37th Annual Roth ConferenceDateM...
SEC Filings
| Date | Form | Description | Download |
|---|---|---|---|
| Feb 25, 2025 | 8-K | Current Report |      |
| Feb 25, 2025 | 10-K | Annual Report - 2024 FY | |
| Feb 11, 2025 | 4 | Statement of Changes in Beneficial Ownership for Mosseri Marlio Charles |
|
| Feb 6, 2025 | 8-K | Current Report | |
| Feb 6, 2025 | 424B5 | Prospectus 424B5 |
|
| Feb 4, 2025 | 424B5 | Prospectus 424B5 |
|
| Jan 3, 2025 | S-8 | Securities Registration: Employee Benefit Plan |
|
| Jan 3, 2025 | 4 | Statement of Changes in Beneficial Ownership for Shemesh Shay |
|
| Jan 3, 2025 | 4 | Statement of Changes in Beneficial Ownership for Poradosu Enrique |
|
| Jan 3, 2025 | 4 | Statement of Changes in Beneficial Ownership for Carson Michael J. |
|